CROOKE STANLEY T 4
4 · IONIS PHARMACEUTICALS INC · Filed Jan 20, 2021
Insider Transaction Report
Form 4
CROOKE STANLEY T
DirectorChairman, President, CEO
Transactions
- Exercise/Conversion
Common Stock
2021-01-15+4,371→ 4,545 total(indirect: By Spouse) - Tax Payment
Common Stock
2021-01-15$61.28/sh−1,434$87,876→ 3,111 total(indirect: By Spouse) - Award
Restricted Stock Units
2021-01-15+5,333→ 5,333 total→ Common Stock (5,333 underlying) - Exercise/Conversion
Restricted Stock Units
2021-01-15−4,371→ 7,801 total(indirect: By Spouse)→ Common Stock (4,371 underlying) - Exercise/Conversion
Common Stock
2021-01-15+47,257→ 49,278 total - Tax Payment
Common Stock
2021-01-15$61.28/sh−18,924$1,159,663→ 30,354 total - Exercise/Conversion
Restricted Stock Units
2021-01-15−47,257→ 87,885 total→ Common Stock (47,257 underlying)
Holdings
- 569,391(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Acquired pursuant to vesting and release of shares in accordance with Restricted Stock Unit awards.
- [F2]Shares withheld to cover the required tax withholding obligations pursuant to the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan.
- [F3]Grant to reporting person of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan.
- [F4]Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
- [F5]Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid out in whole shares of Ionis common stock or cash as may be determined by Ionis.